March 7, 2017 / 4:33 PM / 7 months ago

BUZZ-Deutsche Bank cuts PTs of Valeant, Endo

** Canadian drugmaker Valeant’s U.S.-listed shares down as much as 8.46 pct at $11.36; lowest since June 2009

** Specialty drugmaker Endo’s shares fall as much as 8.86 pct to $10.39 - lowest since March 2003

** Deutsche Bank cuts EPS estimate on VRX, citing higher spending and interest expense assumptions; PT cut to $19 from $20

** Endo PT cut to $18 from $20 by brokerage, based primarily on lower generics sales, partially offset by margin expansion due to restructuring

** Valeant is seeking to refinance and amend existing credit agreement, borrow under credit agreement and issue new secured debt securities

** Up to Monday’s close, VRX’s stock had fallen 14.53 pct and ENDP’s stock had fallen 30.78 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below